Methods of treatment using CTLA-4 antibodies
US7452535B2 · kind B2 · utility
46Cited by
62References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2003 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Oct 19, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55516
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides method of treatment using human sequence antibodies against human CTLA-4. In particular, methods of treating cancer are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.